You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

primary systemic amyloidosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

Active, not recruiting
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Denver, Colorado
  • +4 more
Jan 20, 2023

Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)

Active, not recruiting
Has Results
  • Primary Systemic Amyloidosis
  • Light Chain Deposition Disease
  • Denver, Colorado
  • +6 more
Aug 24, 2022

Screening for Systemic Amyloidosis Via the Ligamentum Flavum

Completed
  • Amyloid
  • +4 more
  • Biopsy
  • Cleveland, Ohio
    Cleveland Clinic
Dec 21, 2021

Primary Systemic Amyloidosis Trial in Milwaukee (Doxycycline)

Completed
Has Results
  • Primary Systemic Amyloidosis
  • Milwaukee, Wisconsin
    Froedtert & Medical College of Wisconsin
Jun 18, 2021

Amyloidosis Trial in Athens (Lenalidomide, Dexamethasone and Cyclophosphamide)

Completed
  • Amyloidosis
  • Lenalidomide, Dexamethasone and Cyclophosphamide
  • Athens, Attica, Greece
    Alexandra Hospital , Department of Clinical Therapeutics
Apr 27, 2021

Amyloidosis, Light Chain (AL) Amyloidosis Trial (Bendamustine Hydrochloride, Isatuximab)

Withdrawn
  • Amyloidosis
  • Light Chain (AL) Amyloidosis
  • (no location specified)
Dec 29, 2022

Light Chain Amyloidosis Trial (FKC288)

Not yet recruiting
  • Light Chain Amyloidosis
  • (no location specified)
Jul 30, 2023

Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)

Recruiting
  • Amyloidosis, Primary
  • Cardiomyopathy
  • F-18 florbetapir/C-11 acetate PET
  • +2 more
  • Boston, Massachusetts
    Brigham and Womens' Hospital
Oct 23, 2022

Amyloidosis; Systemic Trial in Woolloongabba, Box Hill (AT02)

Not yet recruiting
  • Amyloidosis; Systemic
  • Woolloongabba, Queensland, Australia
  • +1 more
Jul 11, 2023

Amyloidosis, Transthyretin Amyloidosis Trial in Portland (124I-Evuzamitide)

Recruiting
  • Amyloidosis
  • Transthyretin Amyloidosis
  • 124I-Evuzamitide
  • Portland, Oregon
    Oregon Health & Science University
Feb 24, 2023

AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease Trial in San Francisco (Venetoclax, Dexamethasone,

Not yet recruiting
  • AL Amyloidosis
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 16, 2022

Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,

Recruiting
  • Systemic Amyloidosis
  • 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
  • 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
  • Knoxville, Tennessee
    University of Tennessee Graduate School of Medicine
Jul 10, 2023

Systemic Transthyretin Amyloidosis: Carpal Tunnel Syndrome

Recruiting
  • Transthyretin Amyloidosis
  • Carpal Tunnel Syndrome
  • Synovial biopsy and Cardiac scintigraphy with [99mTc]Tc-DPD
  • Porto, Portugal
    Centro Hospitalar Universitário São João
Jan 12, 2023

Light Chain (AL) Amyloidosis Trial in New York (STI-6129)

Recruiting
  • Light Chain (AL) Amyloidosis
  • STI-6129
  • Duarte, California
  • +3 more
Jan 12, 2023

Light Chain (AL) Amyloidosis Trial (STI-6129)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • STI-6129
  • (no location specified)
Jan 11, 2023

Multiple Myeloma Trial in Boston (filgrastim, melphalan, autologous peripheral blood stem cell transplantation)

Completed
  • Multiple Myeloma
  • Boston, Massachusetts
    Cancer Research Center at Boston Medical Center
Sep 15, 2020

Systemic Amyloidosis Trial in Knoxville (124I-p5+14 Injection)

Completed
  • Systemic Amyloidosis
  • 124I-p5+14 Injection
  • Knoxville, Tennessee
    University of Tennessee Medical Center
Mar 23, 2022

Amyloidosis Trial in Berkeley, Sacramento, San Jose (I124-AT01 only)

Active, not recruiting
  • Amyloidosis
  • I124-AT01 only
  • Berkeley, California
  • +2 more
Sep 12, 2022

Amyloidosis; Systemic Trial in Knoxville (124I-AT03)

Recruiting
  • Amyloidosis; Systemic
  • Knoxville, Tennessee
    University of Tennessee Medical Center
Mar 14, 2022

Amyloidosis; Systemic Trial in Beijing (Daratumumab, Bortezomib, Dexamethasone)

Active, not recruiting
  • Amyloidosis; Systemic
  • Beijing, China
    Peking Union Medical College Hospital
May 9, 2022

Amyloidosis; Systemic Trial in Boston (Propylene Glycol-Free Melphalan Hydrochloride)

Terminated
  • Amyloidosis; Systemic
  • Propylene Glycol-Free Melphalan Hydrochloride
  • Boston, Massachusetts
    Boston Medical Center
Jul 1, 2022

Systemic Amyloidosis Trial in Knoxville (Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01))

Active, not recruiting
  • Systemic Amyloidosis
  • Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01)
  • Knoxville, Tennessee
    University of Tennessee Graduate School of Medicine
Jul 28, 2023

Outcome of Patients With Systemic AL Amyloidosis in Europe

Completed
  • AL Amyloidosis
    • Wien, Austria
    • +12 more
    Sep 26, 2022

    Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop

    Recruiting
    • Arrythmia
    • +3 more
    • LINQ device - implantable cardiac monitor - referred to in the application as "implantable loop recorder" or "ILR")
    • London, United Kingdom
      Royal Free London NHS Foundation Trust
    Sep 29, 2021

    Natural History of Severe Allergic Inflammation and Reactions

    Recruiting
    • PGM3 Deficiency
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 24, 2023